Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISPERDAL vs RITUXIMAB-ARRX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISPERDAL vs RITUXIMAB-ARRX: Safety Overview

Metric RISPERDAL RITUXIMAB-ARRX
Total FAERS Reports 530 347
Deaths Reported 53 11
Death Rate 10.0% 3.2%
Hospitalizations 235 21
Average Patient Age 44.7 yrs 57.0 yrs
% Female Patients N/A 60.6%
Marketing Status N/A Prescription